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Figure S1: SARS-CoV-2 protein stability comparisons. A) Wt S was transfected into Vero or A549 cells, 
metabolically labeled for one hour, and chased for times indicated.  Blots (shown in Fig 1a) were quantified 
using band densitometry.  Both percent cleavage and percent stability are shown. B) Overall protein stability at 
each time point from blots in Fig. 1D were quantified.  C) Overall protein stability at each time point from blots 
in Fig. 3B were quantified.  D) Overall protein stability at each time point from blots in Fig. 4B were quantified. 
E) Vero cells expressing wt S or the indicted mutants were metabolically labeled for 5 hours. The predicted 















Figure S2: SARS-CoV-2 Spike Luciferase Reporter Gene Assay Controls. a) The experimental schematic 
for the luciferase reporter gene fusion assay used throughout the manuscript is shown here.  In all 
experiments, the target cells used are BSR/T7 cells that constitutively express a T7 polymerase. Effector cells 
used are Vero cells in most experiments and A549 cells in Figure 2c.  b) Various overlay times were tested in a 
luciferase reporter gene assay, effector cells (Vero) were transfected with wt S, and target cells were 
transfected with empty vector (EV) or hACE2.  Results represent three independent experiments, each 
performed in duplicate.  Significance was determined by two-way ANOVA, ****; p<0.001.  c) Endogenous or 
transfection levels of TMPRSS2 and hACE2 were assessed in Vero, A549, and BSR/T7 cells by western blot. 
d) Transfected expression levels of Neuropilin in the experimental conditions from Fig 2d. e) LoVo cells 
transiently expressing S alone, or S with the indicated protease were metabolically labeled for 6 hours. Results 





Figure S3: Mutations made at any of the three potential cleavage sites abolish syncytia formation.  Vero 
cells were transfected with wt S or each of the cleavage mutants.  The first panel shows immunofluorescence 
of wt S or S cleavage mutants (green, magnification bar is 20μm).  The remaining panels show syncytia 
formation at 24 hours post transfection with S or mutants co-expressed with EV, TMPRSS2, or furin.  Syncytia 
are indicated by the black arrows, magnification bar is 100μM.  
